Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
«
»
21 Hits
Search Condition : Filter (MeSH = Carcinoma, Hepatocellular / mortality)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
HuH-7
77179
Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.
Oncotarget
2014-11-15
Pubmed
Full text
Human and Animal Cells
HL60(RCB0041)
77174
Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.
Diagn Mol Pathol
2002-3-1
Pubmed
Full text
Human and Animal Cells
HuH-7
72590
Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma.
Clin Cancer Res
2014-12-15
Pubmed
Full text
Human and Animal Cells
HuH-7(RCB1366)
68763
Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.
Cell Death Dis
2021-11-18
Pubmed
Full text
Human and Animal Cells
KMST-6(RCB1955)
,
Hep G2(RCB1648)
,
HuH-7(RCB1366)
68538
Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.
Int J Mol Sci
2018-5-13
Pubmed
Full text
Human and Animal Cells
HuH-6(RCB1367)
67547
Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.
PLoS Genet
2015-7-1
Pubmed
Full text
Human and Animal Cells
HuH-7
66855
ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma.
Cancer Res
2020-6-15
Pubmed
Full text
Human and Animal Cells
Hep G2
65836
Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma.
Sci Rep
2017-11-14
Pubmed
Full text
Human and Animal Cells
HuH-7
64617
A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma.
Cancer Res
2021-3-1
Pubmed
Full text
Human and Animal Cells
Li-7(RCB1941)
64615
Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.
Med Oncol
2016-11-1
Pubmed
Full text
Human and Animal Cells
HuH-7
63003
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma.
Br J Cancer
2020-11-1
Pubmed
Full text
Human and Animal Cells
HuH-7
62757
Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.
Med Oncol
2016-7-1
Pubmed
Full text
Human and Animal Cells
HuH-7
62247
Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Cancer Lett
2015-1-28
Pubmed
Full text
Human and Animal Cells
HuH-7
44952
High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma.
PLoS One
2014-1-1
Pubmed
Full text
Human and Animal Cells
Hep G2
44719
High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.
Int J Cancer
2014-5-1
Pubmed
Full text
Human and Animal Cells
HuH-7
44688
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Hepatology
2014-3-1
Pubmed
Full text
Human and Animal Cells
HuH-7(RCB1366)
44125
LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Eur J Cancer
2013-3-1
Pubmed
Full text
Human and Animal Cells
K562(RCB0027)
39300
Expression of MAGE genes and survival in patients with hepatocellular carcinoma.
Int J Oncol
1999-12-1
Pubmed
Full text
Human and Animal Cells
38505
Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma.
J Gastroenterol Hepatol
2011-3-1
Pubmed
Full text
Human and Animal Cells
HuH-6(RCB1367)
,
HuH-7
38364
Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Clin Exp Med
2017-2-1
Pubmed
Full text